These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35390228)

  • 41. CD38 promotes angiotensin II-induced cardiac hypertrophy.
    Guan XH; Hong X; Zhao N; Liu XH; Xiao YF; Chen TT; Deng LB; Wang XL; Wang JB; Ji GJ; Fu M; Deng KY; Xin HB
    J Cell Mol Med; 2017 Aug; 21(8):1492-1502. PubMed ID: 28296029
    [TBL] [Abstract][Full Text] [Related]  

  • 42. GDF11 Attenuated ANG II-Induced Hypertrophic Cardiomyopathy and Expression of ANP, BNP and Beta-MHC Through Down- Regulating CCL11 in Mice.
    Zhang C; Wang Y; Ge Z; Lin J; Liu J; Yuan X; Lin Z
    Curr Mol Med; 2018; 18(10):661-671. PubMed ID: 30714521
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mst1 knockout enhances cardiomyocyte autophagic flux to alleviate angiotensin II-induced cardiac injury independent of angiotensin II receptors.
    Cheng Z; Zhang M; Hu J; Lin J; Feng X; Wang S; Wang T; Gao E; Wang H; Sun D
    J Mol Cell Cardiol; 2018 Dec; 125():117-128. PubMed ID: 30193956
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Atrial natriuretic peptide suppresses endothelin gene expression and proliferation in cardiac fibroblasts through a GATA4-dependent mechanism.
    Glenn DJ; Rahmutula D; Nishimoto M; Liang F; Gardner DG
    Cardiovasc Res; 2009 Nov; 84(2):209-17. PubMed ID: 19546173
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phosphorylation of the chromatin remodeling factor DPF3a induces cardiac hypertrophy through releasing HEY repressors from DNA.
    Cui H; Schlesinger J; Schoenhals S; Tönjes M; Dunkel I; Meierhofer D; Cano E; Schulz K; Berger MF; Haack T; Abdelilah-Seyfried S; Bulyk ML; Sauer S; Sperling SR
    Nucleic Acids Res; 2016 Apr; 44(6):2538-53. PubMed ID: 26582913
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transcription factor CHF1/Hey2 suppresses cardiac hypertrophy through an inhibitory interaction with GATA4.
    Xiang F; Sakata Y; Cui L; Youngblood JM; Nakagami H; Liao JK; Liao R; Chin MT
    Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H1997-2006. PubMed ID: 16603706
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dural effects of oxidative stress on cardiomyogenesis via Gata4 transcription and protein ubiquitination.
    Li T; Zhang X; Jiang K; Liu J; Liu Z
    Cell Death Dis; 2018 Feb; 9(2):246. PubMed ID: 29445146
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction.
    Ainscough JF; Drinkhill MJ; Sedo A; Turner NA; Brooke DA; Balmforth AJ; Ball SG
    Cardiovasc Res; 2009 Feb; 81(3):592-600. PubMed ID: 18703536
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kindlin-2 suppresses transcription factor GATA4 through interaction with SUV39H1 to attenuate hypertrophy.
    Qi L; Chi X; Zhang X; Feng X; Chu W; Zhang S; Wu J; Song Y; Zhang Y; Kong W; Yu Y; Zhang H
    Cell Death Dis; 2019 Nov; 10(12):890. PubMed ID: 31767831
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ginkgolide B Protects Cardiomyocytes from Angiotensin II-Induced Hypertrophy via Regulation of Autophagy through SIRT1-FoxO1.
    Jiang Q; Lu M; Li J; Zhu Z
    Cardiovasc Ther; 2021; 2021():5554569. PubMed ID: 34257705
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiomyocyte-specific deletion of endothelin receptor A rescues aging-associated cardiac hypertrophy and contractile dysfunction: role of autophagy.
    Ceylan-Isik AF; Dong M; Zhang Y; Dong F; Turdi S; Nair S; Yanagisawa M; Ren J
    Basic Res Cardiol; 2013 Mar; 108(2):335. PubMed ID: 23381122
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Telmisartan suppresses cardiac hypertrophy by inhibiting cardiomyocyte apoptosis via the NFAT/ANP/BNP signaling pathway.
    Li X; Lan Y; Wang Y; Nie M; Lu Y; Zhao E
    Mol Med Rep; 2017 May; 15(5):2574-2582. PubMed ID: 28447738
    [TBL] [Abstract][Full Text] [Related]  

  • 53. METTL3-mediated m
    Chen X; Gong W; Shao X; Shi T; Zhang L; Dong J; Shi Y; Shen S; Qin J; Jiang Q; Guo B
    Ann Rheum Dis; 2022 Jan; 81(1):87-99. PubMed ID: 34706873
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CSN6 aggravates Ang II-induced cardiomyocyte hypertrophy via inhibiting SIRT2.
    Mei ZL; Wang HB; Hu YH; Xiong L
    Exp Cell Res; 2020 Nov; 396(1):112245. PubMed ID: 32882218
    [TBL] [Abstract][Full Text] [Related]  

  • 55. YQWY decoction reverses cardiac hypertrophy induced by TAC through inhibiting GATA4 phosphorylation and MAPKs.
    Huang JJ; Xie Y; Li H; Zhang XX; Huang Q; Zhu Y; Gu P; Jiang WM
    Chin J Nat Med; 2019 Oct; 17(10):746-755. PubMed ID: 31703755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oridonin protects against cardiac hypertrophy by promoting P21-related autophagy.
    Xu M; Wan CX; Huang SH; Wang HB; Fan D; Wu HM; Wu QQ; Ma ZG; Deng W; Tang QZ
    Cell Death Dis; 2019 May; 10(6):403. PubMed ID: 31127082
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GATA4 regulates ANF expression synergistically with Sp1 in a cardiac hypertrophy model.
    Hu X; Li T; Zhang C; Liu Y; Xu M; Wang W; Jia Z; Ma K; Zhang Y; Zhou C
    J Cell Mol Med; 2011 Sep; 15(9):1865-77. PubMed ID: 20874724
    [TBL] [Abstract][Full Text] [Related]  

  • 58. JIP3 deficiency attenuates cardiac hypertrophy by suppression of JNK pathway.
    Ma Q; Liu Y; Chen L
    Biochem Biophys Res Commun; 2018 Sep; 503(1):1-7. PubMed ID: 29604277
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MiR-21, MiR-29a, GATA4, and MEF2c Expression Changes in Endothelin-1 and Angiotensin II Cardiac Hypertrophy Stimulated Isl-1
    Zlabinger K; Spannbauer A; Traxler D; Gugerell A; Lukovic D; Winkler J; Mester-Tonczar J; Podesser B; Gyöngyösi M
    Cells; 2019 Nov; 8(11):. PubMed ID: 31717562
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The polycomb protein Ring1B generates self atypical mixed ubiquitin chains required for its in vitro histone H2A ligase activity.
    Ben-Saadon R; Zaaroor D; Ziv T; Ciechanover A
    Mol Cell; 2006 Dec; 24(5):701-711. PubMed ID: 17157253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.